SCHEMBL21022925

SCHEMBL21022925

O=C(OCc1ccccc1)c1cccc(OCc2ccccc2)c1OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
HTT P42858 1/20 0.59
TDP1 Q9NUW8 3/20 0.58
POLB P06746 1/20 0.54
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
SLC6A2 P23975 1/20 0.51
SLC6A3 Q01959 1/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
SGMS2 Q8NHU3 2/20 0.51
TSHR P16473 2/20 0.51
CYP3A4 P08684 1/20 0.51
MAPK1 P28482 1/20 0.51
PTGER1 P34995 1/20 0.50
CASP3 P42574 1/20 0.50
RAB9A P51151 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15716659 0.91 ALDH1A1 (0.67) ALDH1A1HTTTDP1POLBKMT2A
SCHEMBL18499402 0.88 ALDH1A1 (0.55) ALDH1A1HTTTDP1POLBKMT2A
SCHEMBL4415350 0.87 HTT (0.75) ALDH1A1HTTTDP1POLBKMT2A
SCHEMBL1305662 0.87 HPGD (0.57) ALDH1A1HTTTDP1KMT2AMEN1
SCHEMBL1305739 0.86 PTGER1 (0.61) ALDH1A1HTTTDP1KMT2AMEN1
SCHEMBL9574717 0.86 HTT (0.73) ALDH1A1HTTTDP1POLBKMT2A
SCHEMBL31354660 0.85 ALDH1A1 (0.64) ALDH1A1HTTTDP1POLBKMT2A
SCHEMBL16789584 0.85 ALDH1A1 (0.64) ALDH1A1HTTTDP1POLBKMT2A
SCHEMBL691784 0.85 MMP9 (0.51) ALDH1A1HTTPOLBSMN1; SMN2RAB9A
SCHEMBL1681699 0.85 HTT (0.50) ALDH1A1HTTTDP1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11149046-B2 Antibacterial sideromycins Hsiri Therapeutics, Inc. (US) 2021-10-19 US disclosed
US-20190153010-A1 ANTIBACTERIAL SIDEROMYCINS Hsiri Therapeutics, LLC 2019-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11149046-B2 Antibacterial sideromycins SLC40A1, SFXN1, SLC39A14 ALDH1A1 4396/4885HTT 1317/4885TDP1 4684/4885
US-20190153010-A1 ANTIBACTERIAL SIDEROMYCINS SLC40A1, SFXN1, SLC39A14 ALDH1A1 4396/4885HTT 1317/4885TDP1 4684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.